PEBP1 and hepatocellular carcinoma: Using a different approach, it was recently shown in the hepatocellular carcinomas, that somatostatin octapeptide significantly reduced the occurrence of pulmonary metastases in vivo by increasing RKIP levels in the primary tumor [105].